General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Amgen Inc.(MODEST), Eli Lilly and Company(MODEST), Novartis Corporation(MODEST), AstraZeneca Pharmaceuticals(MODEST)
CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Amgen Inc.(MODEST), Eli Lilly and Company(MODEST), Novartis Corporation(MODEST), AstraZeneca Pharmaceuticals(MODEST)
© 2024 American College of Cardiology Foundation. All rights reserved.